Adverse effects | N (%) |
---|---|
Ototoxicity | |
Subjective symptoms | 43/107 (40.2%) |
Hearing impairment seen in audiograms | 30/77 (39.0%) |
Nephrotoxicity | 6/96 (6.2%) |
Vestibular toxicity | 4/107 (3.7%) |
PICC related complications | |
Venous thromboembolism | 7/107 (6.5%) |
Bloodstream infection | 1/107 (0.9%) |
Fatigue | 6/107 (5.6%) |
Skin rash | 5/107 (4.7%) |
Paresthesias | 1/107 (0.9%) |
Restless extremities | 1/107 (0.9%) |